AARVIK THERAPEUTICS
Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.
AARVIK THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2020-01-01
Address:
Fremont, California, United States
Country:
United States
Website Url:
http://www.aarviktx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail GoDaddy DNS
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Employees Featured
Founder
Official Site Inspections
http://www.aarviktx.com Semrush global rank: 5.78 M Semrush visits lastest month: 1.44 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Aarvik Therapeutics"
Aarvik Therapeutics - Crunchbase Company Profile
Organization. Aarvik Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Aarvik Therapeutics is a biotechnology company dedicated to engineering โฆSee details»
About 1 - Aarvik Therapeutics, Inc.
Jagath is also a co-founder and Board Chairman at Science Gurus (www.sciencegurus.org), a non-profit organization that fosters in developing NextGen Scientists. Statement: Aarvik is a 20yr dream for the co-founders โฆSee details»
Aarvik Therapeutics Inc Management Team | Org Chart
Aarviktx.com; 1 925249XXXX; Jagath Junutula President and Chief Executive Officer at Aarvik Therapeutics Inc Fremont, CA, US View. 2 gmail.com; aarviktx.com; 2 510565XXXX; โฆSee details»
Aarvik Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Aarvik Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Aarvik Therapeutics Inc Overview | SignalHire Company Profile
Organization Website. aarviktx.com . Aarvik Therapeutics Inc industries. Biotech Headquarters Location. 31363 Medallion Dr, Hayward, California, 94544 US. Aarvik Therapeutics Inc โฆSee details»
Aarvik Therapeutics Company Profile | Management and
Www.aarviktx.com . Aarvik Therapeutics Profile and History. Founded in 2021 an headquartered in Fremont, California, Aarvik Therapeutics is a biotechnology company with a focus on novel โฆSee details»
Aarvik Therapeutics - Overview, News & Similar companies
Aug 24, 2023 www.aarviktx.com. Revenue <$5 Million. Industry Education General Education . Recent News & Media. Aarvik Therapeutics Announces a Global Novel Payload Agreeme...See details»
About 1 โ Aarvik Therapeutics, Inc.
Prior to that, as Vice President, Research Operations and Structural Biology, she coordinated all operational activities for the more than 1300-member Genentech research organization, while โฆSee details»
Aarvik Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Aarvik Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 13 news, and 2 literature.See details»
Aarvik Therapeutics Inc Overview - Salary.com
Discover essential details about Aarvik Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Aarvik Therapeutics - Company Profile - Tracxn
Nov 5, 2024 Aarvik Therapeutics ranks 1,303rd among 2439 active competitors. 865 of its competitors are funded while 580 have exited. Overall, Aarvik Therapeutics and its โฆSee details»
Aarvik Therapeutics Inc | LinkedIn
Aarvik Therapeutics Inc | 1,129 followers on LinkedIn. Engineering Precision Medicines | Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for โฆSee details»
General 1 โ Aarvik Therapeutics, Inc.
Our founders created the THIOMAB platform to develop site-specific antibody-drug conjugation technology and common light chain libraries in their previous/current industry/academic careers.See details»
Aarvik Therapeutics, Inc. (Aarvik Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Abstract Background: Trophoblast antigen 2 (Trop2) or Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) is a transmembrane glycoprotein that is overexpressed in several โฆSee details»
Aarvik Therapeutics Company Profile - Selligence
Aarvik Therapeutics is a biotechnology company dedicated to engineering precision therapies for oncology targets.See details»
Contact โ Aarvik Therapeutics, Inc.
Join Our Team Science PlatformSee details»
Aarvik Therapeutics Announces Option Exercise by Collaboration โฆ
Aug 15, 2024 HAYWARD, Calif.--(BUSINESS WIRE)-- Aarvik Therapeutics, a biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to โฆSee details»
Services 2 - Aarvik Therapeutics, Inc.
We were there at the early stages of Antibody Drug Conjugates (ADCs) and have carefully studied the innovations done so far. We questioned the fundamentals to understand why there โฆSee details»
General 2 โ Aarvik Therapeutics, Inc.
Aarvik Therapeutics and ArriVent Biopharma Announce Research Collaboration to Advance Novel Oncology Drug Candidate Using Aarvikโs Proprietary Modular Antibody PlatformSee details»